Lumito Arrow right Arrow right

Roland Andersson

Education and background: Solid clinical experience and clinical and transitional research. Author of more than 500 articles in peer-reviewed journals. Supervisor for about 30 completed graduate students in the areas of cancer, systematic inflammation, organ failure and bowel function. Board member at Aqilion AB, Reccan Diagnostics AB and Nordic Biotechnology AB. Number of shares: 0 Number of warrants: 0 Independent of company, independent of larger shareholders.

Read More

Ulf Bladin

Education and background: Medical candidate from Karolinska Institutet, B.Sc. and Master from Stockholm School of Economics. Currently CEO of Prolight Diagnostics. Has previously been, among other things, General Manager, Vice President of EMEA Region at Hycor Biomedical, Vice President Commercial Operations Europe at Thermo Fisher Scientific Immuno Diagnostics Division, Vice President with global responsibility for Marketing, Health Economy, Corporate Communications, Scientific & Regulatory Affairs at Phadia AB. Ulf Bladin has also held leading commercial positions in the pharmaceutical industry at Pfizer and Merck Sharp & Dohme. Shares held privately and via related parties: 120,000 Independent of company, independent of larger…

Read More

Urban Widén

Education and background: International leader with more than 30 years of experience in the pharma industry, including 20 years as CEO in life science companies such as AstraZene­ca Hungary, Schering-Plough and Organon Biosciences Sweden, AutomationsPart­ner Sweden and Fürst Medicinskt Laboratorium Filial Sweden. Extensive industrial and technical knowledge in diagnostics, automation, digital pathology, global marketing, acquisitions, organic growth and implementation of efficiency measures. Number of shares: 0 Number of warrants: 0 Dependent of company, independent of larger shareholders.

Read More

Stefan Andersson-Engels

Education and background: Professor of physics at Lund University until 2016. Since 2016 director of Biophotonics at Tyndall National Institute, Ireland. Postdoc at McMasters University in Hamilton, Ontario, Canada. Received Erna Ebeling's award, Swedish Society for Medical Technology and Physics, 2003. First-time candidate for the appointment of the biomedical physics professor at the Royal Institute of Technology, Stockholm 1996. Co-author of more than 200 articles in peer-reviewed journals. Share of shares privately and through related parties: 2,100,000 Number of warrants: 0 Dependent in relation to the company's major shareholders, but independent in relation to the company and company's management.

Read More